Form 8-K - Current report:
SEC Accession No. 0001104659-23-059454
Filing Date
2023-05-12
Accepted
2023-05-12 08:35:20
Documents
14
Period of Report
2023-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2315281d1_8k.htm   iXBRL 8-K 25317
2 EXHIBIT 99.1 tm2315281d1_ex99-1.htm EX-99.1 63402
6 GRAPHIC tm2315281d1_ex99-1img001.jpg GRAPHIC 12372
  Complete submission text file 0001104659-23-059454.txt   288340

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA atxi-20230512.xsd EX-101.SCH 3033
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxi-20230512_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxi-20230512_pre.xml EX-101.PRE 22595
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2315281d1_8k_htm.xml XML 3590
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

EIN.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38114 | Film No.: 23913389
SIC: 2834 Pharmaceutical Preparations